Developmental Immunotoxicity Study of Tris(chloropropyl) phosphate (TCPP) in Hsd:Sprague Dawley SD Rats Exposed Through Dosed Feed
Victor J. Johnson1, Kristen Ryan2, Michael I. Luster1, Arun Pandiri2, Kristen Hobbie3, Michelle Cora2, Keith R. Shockley4, Gary R. Burleson1, Guanhua Xie5, Dori R. Germolec2
1 Burleson Research Technologies, Inc, Morrisville, NC 27560, United States
2 Division of Translational Toxicology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, United States
3 Inotiv, Inc, Morrisville, NC 27560, United States
4 Division of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, United States
5 DLH, LLC, Bethesda, MD 27703, United States
Toxicological Sciences, (2025) DOI:
https://doi.org/10.1093/toxsci/kfaf006 PMID:
39908456
PMCID:
PMC12038234
DOI: https://doi.org/10.22427/NTP-DATA-500-002-002-000-9
Abstract
Tris(chloropropyl) phosphate (TCPP) is a member of organophosphate flame retardants used commonly as a replacement for polybrominated diphenyl ethers in consumer and commercial products. Flame retardants have been shown to modulate immune function in vivo and in vitro and there is evidence that at least some related compounds such as organophosphate pesticides can cause developmental immunotoxicity. Developmental immunotoxicology studies were conducted by administering 0, 2500, 5000, or 10,000ppm TCPP in feed to pregnant Hsd:Sprague Dawley SD rats from gestation day 6 through weaning on postnatal day 28. Feed exposure to TCPP was continued in the F1 offspring until terminal euthanasia at .16 to 21weeks of age when assessments for developmental immunotoxicity were conducted. Innate, humoral, and cell-mediated immune function were assessed in the F1 adults. The antibody-forming cells (AFCs) response to sheep red blood cells was reduced in male and female F1 rats in the 10,000ppm treatment group but coincided with reduced bodyweights. The AFC response was also significantly reduced in male rats exposed to 5000ppm where only moderate effects on bodyweights occurred. TCPP exposure affected baseline T-cell proliferation without stimulation; however, the relevance of this change for immunotoxicity risk is unknown. TCPP exposure did not affect cytotoxic T-lymphocyte activity. Only minor and inconsistent treatment-related effects on hematology, innate NK cell function, and immune cell population distributions in the spleen were observed. Taken together, these data indicate that TCPP has the potential to impact humoral immune responses following developmental exposure.
Study Tables
- I01 - Animal Removal Summary (156 KB)
- I02 - Animal Removals (3 MB)
- I04 - Mean Body Weight Summary (1 MB)
- I04G - Mean Body Weight Gain (761 KB)
- I05 - Clinical Observations Summary (224 KB)
- I05P - Pup Clinical Observations Summary (383 KB)
- I06 - Mean Feed Consumption (1 MB)
- I08 - Mean Test Compound Consumption (710 KB)
- M03 - Peripheral Blood Leukocyte Cell Differential (37 KB)
- M04 - Hematology (37 KB)
- M06 - Spleen Immunophenotyping (40 KB)
- M07 - TDAR SRBC Spleen AFC (34 KB)
- M08 - Serum IgM Antibody Titers to T-Dependent Antigen Sheep Erythrocytes (32 KB)
- M09 - Serum Antibody Concentrations for the T-Dependent Keyhole Limpet Hemocyanin (KLH) (32 KB)
- M10 - Thymus Immunophenotyping (39 KB)
- M11 - Spleen Cell Proliferative Response to Anti-CD3 Stimulation (36 KB)
- M12 - Cytotoxic T Cell Activity (33 KB)
- M15 - Natural Killer Cell Activity (33 KB)
- M19 - TDAR SRBC ELISpot (34 KB)
- PA03 - Nonneoplastic Lesion Summary with Percent Incidence (239 KB)
- PA06 - Organ Weights Summary (56 KB)
- PA18 - Incidence Rates of Nonneoplastic Lesions by Anatomic Site with Average Severity Grade (240 KB)
- PA46 - Summary of Gross Pathology (713 KB)
- R02 - Reproductive Performance Summary (38 KB)
- R03 - Summary of Litter Data (77 KB)
- R19 - Pup Mean Body Weight Summary (132 KB)
- R19C - Pup Growth Curve (755 KB)
- R19G - Pup Mean Body Weight Gain (111 KB)
Individual Animal Data
- Individual Animal Anti - SRBC IgM ELISpot Data (11 KB)
- Individual Animal Anti - SRBC Serum IgM Antibody Response Data (9 KB)
- Individual Animal Body Weight Data (390 KB)
- Individual Animal Clinical Observations Data (2 MB)
- Individual Animal Consumption Data (455 KB)
- Individual Animal Cytotoxic T Cell Activity Data (20 KB)
- Individual Animal Gross Pathology Data (68 KB)
- Individual Animal Hematology Data (21 KB)
- Individual Animal KLH TDAR Data (10 KB)
- Individual Animal Litter Data (169 KB)
- Individual Animal Natural Killer Cell Activity Data (20 KB)
- Individual Animal Organ Weight Data (44 KB)
- Individual Animal Pup Body Weight Data (229 KB)
- Individual Animal Pup Clinical Observations Data (1 MB)
- Individual Animal Removal Reasons Data (33 KB)
- Individual Animal Reproductive Performance Data (9 KB)
- Individual Animal Spleen Anti - CD3 Proliferation Data (17 KB)
- Individual Animal Spleen Antibody Forming Cell Response Data (12 KB)
- Individual Animal Spleen Immunophenotyping Data (18 KB)
- Individual Animal Thymus Immunophenotyping Data (14 KB)
Updates
Publication DOI details added on July 29th, 2026